Visgenx to Present at the 4th Annual Dry AMD Therapeutic Development Summit
Visgenx Announces Issuance of a U.S. Patent Claiming Compositions of Candidate ELOVL2...
Visgenx Poster: Advancing Next Generation Therapies, West Coast Symposium
Visgenx Presents Poster at the Cell and Gene Therapy: Advancing Next Generation...
Visgenx Announces Positive Results from a Key Translational Study for its Gene...
Visgenx Appoints William Pedranti as Chief Executive Officer
Attending BIO 2023? Click below to send Visgenx a meeting request in the...
Visgenx to present at the American Society of Gene and Cell Therapy...